L.N. 231 of 2008 MEDICINES ACT (CAP. 458) Medicines (Marketing Authorisation) (Amendment) Regulations, 2008

These regulations amend the existing Medicines (Marketing Authorisation) Regulations. They update the rules for granting marketing authorisations for medicinal products. This affects pharmaceutical companies seeking to market medicines in Malta. It ensures compliance with updated EU standards and procedures for drug approval.